Gujarat Themis Biosyn Limited (GUJTHEM.BO)
INR 275.25
(0.95%)
INR 275.25
(0.95%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 197.37 Million INR | 14.87% |
| 2022 | 171.82 Million INR | -10.41% |
| 2021 | 191.79 Million INR | 4.7% |
| 2020 | 183.17 Million INR | -16.28% |
| 2019 | 218.8 Million INR | 53.67% |
| 2018 | 142.38 Million INR | 69.86% |
| 2017 | 83.82 Million INR | -36.6% |
| 2016 | 132.2 Million INR | 10.68% |
| 2015 | 119.45 Million INR | -22.92% |
| 2014 | 154.97 Million INR | -27.51% |
| 2013 | 213.78 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -2.01 Billion INR | -1120.28% |
| 2024 Q2 | 247.15 Million INR | 112.27% |
| 2023 FY | 197.37 Million INR | 14.87% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 197.37 Million INR | 0.0% |
| 2023 Q2 | 193.9 Million INR | 0.0% |
| 2022 Q2 | 265.76 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 171.82 Million INR | -10.41% |
| 2022 Q4 | 171.82 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 191.79 Million INR | 0.0% |
| 2021 Q2 | 193.79 Million INR | 0.0% |
| 2021 FY | 191.79 Million INR | 4.7% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 183.17 Million INR | 0.0% |
| 2020 Q2 | 205.9 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 183.17 Million INR | -16.28% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 218.8 Million INR | 53.67% |
| 2019 Q4 | 218.8 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 262.29 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 114.79 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 142.38 Million INR | 0.0% |
| 2018 FY | 142.38 Million INR | 69.86% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 100.18 Million INR | 0.0% |
| 2017 FY | 83.82 Million INR | -36.6% |
| 2017 Q4 | 83.82 Million INR | 0.0% |
| 2016 Q4 | 133.41 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q2 | 128.76 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 132.2 Million INR | 10.68% |
| 2015 Q2 | 146.78 Million INR | 0.0% |
| 2015 Q4 | 108.34 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 FY | 119.45 Million INR | -22.92% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q2 | 184.27 Million INR | 0.0% |
| 2014 Q4 | 154.97 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 FY | 154.97 Million INR | -27.51% |
| 2013 Q2 | 251.54 Million INR | 0.0% |
| 2013 FY | 213.78 Million INR | 0.0% |
| 2013 Q4 | 213.78 Million INR | 0.0% |
| 2012 Q4 | 279.3 Million INR | 0.0% |
| 2011 Q4 | 313.52 Million INR | 0.0% |
| 2008 Q4 | 234.73 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.7 Million INR | -667.956% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 86.847% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 80.191% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -840.319% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -267.911% |
| Sunil Healthcare Limited | 902.83 Million INR | 78.138% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -9175.047% |
| MedPlus Health Services Limited | 14.27 Billion INR | 98.617% |
| Zenith Healthcare Limited | 24.03 Million INR | -721.19% |
| Patidar Buildcon Limited | 25.57 Million INR | -671.832% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -27.284% |
| Roopa Industries Limited | 493.08 Million INR | 59.972% |
| Smruthi Organics Limited | 485.72 Million INR | 59.365% |
| Trident Lifeline Limited | 331.26 Million INR | 40.418% |
| Bacil Pharma Limited | 1.12 Million INR | -17382.108% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | 5.31% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -22.081% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 80.348% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -66.95% |
| PANJON LTD. | 25.38 Million INR | -677.579% |
| Tyche Industries Limited | 101.64 Million INR | -94.186% |
| Trimurthi Limited | 101.36 Thousand INR | -194624.743% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -1217.665% |
| Anuh Pharma Limited | 1.54 Billion INR | 87.222% |
| Crestchem Limited | 23.94 Million INR | -724.208% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -1372.383% |
| Zenlabs Ethica Limited | 301.35 Million INR | 34.505% |
| Vikram Thermo (India) Limited | 291.47 Million INR | 32.285% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 88.121% |
| Parmax Pharma Limited | 117.56 Million INR | -67.88% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 89.396% |
| Deccan Health Care Limited | 111.33 Million INR | -77.277% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | 2.278% |
| Norris Medicines Limited | 278.17 Million INR | 29.047% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 88.486% |
| Veerhealth Care Limited | 62.78 Million INR | -214.388% |
| Makers Laboratories Limited | 569.18 Million INR | 65.323% |
| Lactose (India) Limited | 536.39 Million INR | 63.204% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 76.31% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 82.547% |
| Mercury Laboratories Limited | 171.18 Million INR | -15.295% |
| Gennex Laboratories Limited | 535.21 Million INR | 63.122% |
| PRAVEG LIMITED | 767.53 Million INR | 74.285% |
| Denis Chem Lab Limited | 289.82 Million INR | 31.899% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 88.5% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | 2.093% |
| Colinz Laboratories Limited | 24.1 Million INR | -718.805% |
| Godavari Drugs Limited | 957.86 Million INR | 79.394% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -65911.037% |
| Zenotech Laboratories Limited | 156.64 Million INR | -25.998% |
| Panchsheel Organics Limited | 340.2 Million INR | 41.984% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | 59.585% |
| Vivanza Biosciences Limited | 148.63 Million INR | -32.794% |
| Phaarmasia Limited | 211.49 Million INR | 6.677% |
| Bharat Parenterals Limited | 2.65 Billion INR | 92.57% |
| Medi-Caps Limited | 63.01 Million INR | -213.211% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -67.656% |
| BDH Industries Limited | 312.53 Million INR | 36.848% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -12.677% |
| Coral Laboratories Limited | 281.83 Million INR | 29.97% |
| Concord Drugs Limited | 249.88 Million INR | 21.015% |
| Beryl Drugs Limited | 85.63 Million INR | -130.479% |
| Evoq Remedies Limited | 116.23 Million INR | -69.81% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -23.975% |
| Transchem Limited | 6.72 Million INR | -2837.098% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -2124.673% |
| Parnax Lab Limited | 1.17 Billion INR | 83.141% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -370.249% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 81.339% |
| Cian Healthcare Limited | 1.03 Billion INR | 80.918% |
| Trinity League India Limited | 876 Thousand INR | -22431.164% |
| Syschem (India) Limited | 1.07 Billion INR | 81.566% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 90.339% |
| Natural Capsules Limited | 1.47 Billion INR | 86.639% |
| Auro Laboratories Limited | 433.09 Million INR | 54.428% |